Predictors and surgical outcome of hemorrhagic metastatic brain malignancies - Top-Institutions - MDSpire

Predictors and surgical outcome of hemorrhagic metastatic brain malignancies

  • By

  • Laurèl Rauschenbach

  • Pia Kolbe

  • Adrian Engel

  • Yahya Ahmadipour

  • Marvin Darkwah Oppong

  • Alejandro N. Santos

  • Sied Kebir

  • Celia Dobersalske

  • Björn Scheffler

  • Cornelius Deuschl

  • Philipp Dammann

  • Karsten H. Wrede

  • Ulrich Sure

  • Ramazan Jabbarli

  • May 27, 2024

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Neurosurgery
    • Neuro-oncology
    • Medical Oncology
    • Radiation Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Neurosurgery
    • Neuro-oncology
    • Medical Oncology

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Neurosurgery
    • Neuro-oncology
    • Radiology

  • #4

    Massachusetts General Hospital (MGH)
    Massachusetts General Hospital (MGH)

    Boston, MA

    Key Differentiators

    • Neurosurgery
    • Neuro-oncology
    • Critical Care Medicine

  • #5

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Neurosurgery
    • Neuro-oncology
    • Pathology

Original Source(s)

Predictors and surgical outcome of hemorrhagic metastatic brain malignancies

  • by Laurèl Rauschenbach, Pia Kolbe, Adrian Engel, Yahya Ahmadipour, Marvin Darkwah Oppong, Alejandro N. Santos, Sied Kebir, Celia Dobersalske, Björn Scheffler, Cornelius Deuschl, Philipp Dammann, Karsten H. Wrede, Ulrich Sure, Ramazan Jabbarli

  • May 27, 2024

Related Content

PD-1 inhibitor combined with chemoradiotherapy in two cases of ovarian cancer brain metastases: a case report

Understanding cardiac toxicity and immune responses to thoracic radiation therapy in non-small cell lung cancer – implications for future research

HHLA2 as an emerging immune checkpoint in lung cancer: linking EGFR signaling, macrophage polarization, and CD8+ T-cell metabolic suppression